about
Which botanicals or other unconventional anticancer agents should we take to clinical trial?Health food store recommendations: implications for breast cancer patientsAre herbal remedies and dietary supplements safe and effective for breast cancer patients?Hypericin in the Light and in the Dark: Two Sides of the Same CoinA Review of Integrative Medicine in Gynaecological OncologyRole of pregnane X receptor in chemotherapeutic treatmentAdverse events associated with complementary and alternative medicine use in ovarian cancer patientsAlterations of chemotherapeutic pharmacokinetic profiles by drug-drug interactionsPharmacokinetic interactions of drugs with St John's wort.Irinotecan-induced diarrhea: functional significance of the polymorphic ABCC2 transporter protein.Renal function as a predictor of irinotecan-induced neutropenia.Camptothecin and podophyllotoxin derivatives: inhibitors of topoisomerase I and II - mechanisms of action, pharmacokinetics and toxicity profile.Interactions between herbal medicines and prescribed drugs: an updated systematic review.Drug-botanical interactions: a review of the laboratory, animal, and human data for 8 common botanicals.Therapeutic Risk and Benefits of Concomitantly Using Herbal Medicines and Conventional Medicines: From the Perspectives of Evidence Based on Randomized Controlled Trials and Clinical Risk Management.Traditional Chinese medicine use among Chinese immigrant cancer patients.Effects of methimazole on the elimination of irinotecan.Elucidating the 'Jekyll and Hyde' nature of PXR: the case for discovering antagonists or allosteric antagonists.Complementary and alternative medicine use in oncology: a questionnaire survey of patients and health care professionalsInteractions between herbs and conventional drugs: overview of the clinical data.Interpreting Research on Dietary Supplements and Cancer - What is the Take Home Message?Herbal modulation of P-glycoprotein.Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions.Complementary and alternative medicine: assessing the evidence for immunological benefits.In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypesReview of the regulations for clinical research in herbal medicines in USA.Irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer.How to design a phase I trial of an anticancer botanical.Phospho-ibuprofen (MDC-917) is a novel agent against colon cancer: efficacy, metabolism, and pharmacokinetics in mouse models.Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations.Alternative medicines and the liver.Drug interactions in the hematopoietic stem cell transplant (HSCT) recipient: what every transplanter needs to know.Interaction of St John's wort with conventional drugs: systematic review of clinical trials.Safety and efficacy of herbal sedatives in cancer care.Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjectsDrug development in oncology: classical cytotoxics and molecularly targeted agents.The effect of St John's wort extracts on CYP3A: a systematic review of prospective clinical trials.Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters.Molecular mechanisms of toxicity of important food-borne phytotoxins.Herb-drug interactions: an overview of the clinical evidence.
P2860
Q24652544-28BD40A0-82F1-4870-9BCF-7FB165337723Q24802571-D702EEDB-0C10-4393-8D15-74D929BA1386Q24803098-BDC53683-8642-47CA-8E6C-634C6E11C553Q26747362-B20BABF9-8C77-4371-9B67-94658204052CQ26768670-977EFAD6-485B-4710-8DB9-2126709C5520Q26827398-51471572-1712-4D12-91FF-4AD92CC9B2C9Q27022402-6F22C77A-C77D-4D7B-835E-3E13F26AC34AQ28710150-EFEEC819-46E1-4022-9B0F-AD0B2F00ED1DQ33204911-6248AA94-639F-4B15-9651-2D089179C04DQ33267448-FD280EBA-B6A3-488F-9250-4DEF6EC35A13Q33320638-E5E3358F-4910-4745-999E-A3F4CD1D8793Q33370478-6A846DD4-100B-4A97-8B3D-7AC45798F05BQ33498604-09A62371-222F-4F1E-906E-23244ABE7FC4Q33509452-46070D75-3D6E-47A1-9966-C3B506BDC7EEQ33604138-1BB260FA-4A8B-4D64-B1B9-78582EA68ADCQ33612897-B23202F4-D10D-4579-B962-C959FD498C82Q33647853-943E25E7-5B3A-4451-84F7-09C5FADAA726Q33756500-51FA6421-DBDE-47E6-9567-A22BF48198A5Q33910457-4016C807-93EF-411A-9466-92C329089295Q34124444-16E46A48-37A3-41C5-A45A-1F251A9D874FQ34206038-47261F8D-4A00-4525-BF44-AAAE20D7FC8EQ34312035-3C715A3D-E351-4A20-8BFB-7508BDF012F4Q34360600-7A44797E-2A97-423D-B139-F74C846D46F1Q34363569-B6591A74-16E3-4895-A0DE-B2F1F8AC4B5CQ34419646-6C512F20-7CA9-4A08-9BCD-23ED49315068Q34449725-D5B21E49-83AC-432B-B440-5074DB9D27AFQ34504536-42DD3196-A873-4342-A924-096B3645A990Q34943646-5FAF2019-C00D-4BA8-90CF-16B66DEE6AC4Q35003113-5FC89EB1-778F-43CC-AA39-C625C3EF648CQ35009679-A174E9C5-CFBE-4391-832E-DD5AA62BC34CQ35190676-21636516-2F8A-4069-98A7-3731BD186CA7Q35608207-4C8CC962-45C4-4CEE-AAF6-8AC3EBE575F9Q35615173-240CAA0D-2449-4D09-B963-CD299AE9A898Q35785444-E6287939-4F7D-441D-8514-5EC3A5158AD4Q35826093-4D7151C9-1324-4F2D-AEFA-D6405C6D3A3EQ35827606-9BE77E47-1791-4164-BAB2-6CA63DD06A7EQ35827865-EC63550D-B72D-49AD-A2AF-0AB3CB68F421Q35919726-52D4B2AD-9B5E-43B5-B6B4-7C0AC1E10EE7Q36001268-06DF1F5A-6FE1-4B40-97F8-28DB957A544BQ36014951-03CA3AF5-15FE-4A8E-B1F5-2CFE5E50E051
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Effects of St. John's wort on irinotecan metabolism.
@ast
Effects of St. John's wort on irinotecan metabolism.
@en
type
label
Effects of St. John's wort on irinotecan metabolism.
@ast
Effects of St. John's wort on irinotecan metabolism.
@en
prefLabel
Effects of St. John's wort on irinotecan metabolism.
@ast
Effects of St. John's wort on irinotecan metabolism.
@en
P2093
P356
P1476
Effects of St. John's wort on irinotecan metabolism.
@en
P2093
Jaap Verweij
Peter de Bruijn
Ron H J Mathijssen
Walter J Loos
P304
P356
10.1093/JNCI/94.16.1247
P407
P577
2002-08-01T00:00:00Z